EUVIMEDEUVIMED entdecken
Crossref

The Huntington’s Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure

Olivia S Brumfield, Christine E Zizzi, Nuran Dilek, Danae G Alexandrou, Alistair M Glidden, Spencer Rosero, Jennifer Weinstein, Jamison Seabury, Aaron Kaat, Michael P McDermott, E Ray Dorsey, Chad R Heatwole

Journal of Huntington's Disease · 03.06.2022 · 11 (2) · 217-226

DOI: 10.3233/jhd-210506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Huntington's Disease, erschienen am 03.06.2022. Verfasst von Olivia S Brumfield und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health + Technology, University of Rochester, Rochester, NY, USA. Hauptthemen laut MEDLINE: Huntington Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

When developed properly, disease-specific patient reported outcome measures have the potential to measure relevant changes in how a patient feels and functions in the context of a therapeutic trial. The Huntington’s Disease Health Index (HD-HI) is a multifaceted disease-specific patient reported outcome measure (PROM) designed specifically to satisfy previously published FDA guidance for developing PROMs for product development and labeling claims.

Objective

In preparation for clinical trials, we examine the validity, reliability, clinical relevance, and patient understanding of the Huntington’s Disease Health Index (HD-HI).

Methods

We partnered with 389 people with Huntington’s disease (HD) and caregivers to identify the most relevant questions for the HD-HI. We subsequently utilized two rounds of factor analysis, cognitive interviews with fifteen individuals with HD, and test-retest reliability assessments with 25 individuals with HD to refine, evaluate, and optimize the HD-HI. Lastly, we determined the capability of the HD-HI to differentiate between groups of HD participants with high versus low total functional capacity score, prodromal versus manifest HD, and normal ambulation versus mobility impairment.

Results

HD participants identified 13 relevant and unique symptomatic domains to be included as subscales in the HD-HI. All HD-HI subscales had a high level of internal consistency and reliability and were found by participants to have acceptable content, relevance, and usability. The total HD-HI score and each subscale score statistically differentiated between groups of HD participants with high versus low disease burden.

Conclusion

Initial evaluation of the HD-HI supports its validity and reliability as a PROM for assessing how individuals with HD feel and function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseCaregiversCost of IllnessHumansPatient Reported Outcome MeasuresReproducibility of Results

Stichwörter der Autor:innen

Huntington’s diseaseneurodegenerative disorderpatient reported outcome measurequality of lifetherapeutic trial

Autor:innen und Institutionen

  • Center for Health + Technology, University of Rochester, Rochester, NY, USA.
  • School of Public and International Affairs, Princeton University, Princeton, NJ, USA.
  • Department of Neurology, University of Rochester, Rochester, NY, USA.
  • Department of Medical Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA.

Zitieren

APA

Brumfield, O. S., Zizzi, C. E., Dilek, N., Alexandrou, D. G., Glidden, A. M., Rosero, S., Weinstein, J., Seabury, J., Kaat, A., McDermott, M. P., Dorsey, E. R., & Heatwole, C. R. (2022). The Huntington’s Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure. Journal of Huntington's Disease, 11(2), 217-226. https://doi.org/10.3233/jhd-210506

Vancouver

Brumfield OS, Zizzi CE, Dilek N, Alexandrou DG, Glidden AM, Rosero S, et al. The Huntington’s Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure. Journal of Huntington's Disease. 2022;11(2):217-226. doi:10.3233/jhd-210506

BibTeX
@article{Brumfield2022,
  author = {Brumfield, Olivia S and Zizzi, Christine E and Dilek, Nuran and Alexandrou, Danae G and Glidden, Alistair M and Rosero, Spencer and Weinstein, Jennifer and Seabury, Jamison and Kaat, Aaron and McDermott, Michael P and Dorsey, E Ray and Heatwole, Chad R},
  title = {The Huntington’s Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure},
  journal = {Journal of Huntington's Disease},
  year = {2022},
  volume = {11},
  number = {2},
  pages = {217--226},
  doi = {10.3233/jhd-210506}
}
Kostenlos starten →